SPL Mapping FHIR R5 Implementation Guide, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 0.2.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-spl/ and changes regularly. See the Directory of published versions
Page standards status: Trial-use | Maturity Level: 1 |
{
"resourceType" : "ValueSet",
"id" : "valueset-splOperationType",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet valueset-splOperationType</b></p><a name=\"valueset-splOperationType\"> </a><a name=\"hcvalueset-splOperationType\"> </a><a name=\"valueset-splOperationType-en-US\"> </a><ul><li>Include these codes as defined in <a href=\"http://terminology.hl7.org/6.0.2/CodeSystem-v3-nciThesaurus.html\"><code>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>C101509</td><td>API/FDF ANALYTICAL TESTING</td></tr><tr><td>C101510</td><td>FDF MANUFACTURE</td></tr><tr><td>C101511</td><td>CLINICAL BIOEQUIVALENCE OR BIOAVALABILITY STUDY</td></tr><tr><td>C101512</td><td>IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING</td></tr><tr><td>C112113</td><td>Human Drug Compounding Outsourcing Facility</td></tr><tr><td>C117110</td><td>Business Entity Qualifier</td></tr><tr><td>C118411</td><td>Wholesale Drug Distributor</td></tr><tr><td>C118412</td><td>Third-Party Logistics Provider</td></tr><tr><td>C122061</td><td>Outsourcing Animal Drug Compounding</td></tr><tr><td>C125710</td><td>Transfill</td></tr><tr><td>C175317</td><td>SIP Foreign Seller</td></tr><tr><td>C201565</td><td>Distribute</td></tr><tr><td>C25391</td><td>ANALYSIS</td></tr><tr><td>C43360</td><td>MANUFACTURE</td></tr><tr><td>C70827</td><td>Salvage</td></tr><tr><td>C71586</td><td>EXPORT</td></tr><tr><td>C73330</td><td>UNITED STATES AGENT</td></tr><tr><td>C73599</td><td>IMPORT</td></tr><tr><td>C73606</td><td>REPACK</td></tr><tr><td>C73607</td><td>RELABEL</td></tr><tr><td>C73608</td><td>Distributes drug products under own private label</td></tr><tr><td>C82401</td><td>API MANUFACTURE</td></tr><tr><td>C82434</td><td>OUTSOURCING HUMAN DRUG COMPOUNDING</td></tr><tr><td>C84382</td><td>STERILIZE</td></tr><tr><td>C84386</td><td>PARTICLE SIZE REDUCTION</td></tr><tr><td>C84635</td><td>MEDICATED ANIMAL FEED MANUFACTURE</td></tr><tr><td>C84731</td><td>PACK</td></tr><tr><td>C84732</td><td>LABEL</td></tr><tr><td>C91403</td><td>POSITRON EMISSION TOMOGRAPHY DRUG PRODUCTION</td></tr></table></li></ul></div>"
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode" : "brr"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger" : 1,
"_valueInteger" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical" : "http://hl7.org/fhir/us/spl/ImplementationGuide/hl7.fhir.us.spl"
}
]
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode" : "trial-use",
"_valueCode" : {
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical" : "http://hl7.org/fhir/us/spl/ImplementationGuide/hl7.fhir.us.spl"
}
]
}
}
],
"url" : "http://hl7.org/fhir/us/spl/ValueSet/valueset-splOperationType",
"version" : "0.2.1",
"name" : "SPLOperationType",
"title" : "SPL Operation Type",
"status" : "active",
"experimental" : false,
"date" : "2024-10-26T03:36:34+00:00",
"publisher" : "HL7 International / Biomedical Research and Regulation",
"contact" : [
{
"name" : "HL7 International / Biomedical Research and Regulation",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/rcrim"
}
]
}
],
"description" : "Codes from NCI Thesaurus for SPL Operation Type (C73600 Subset)",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US",
"display" : "United States of America"
}
]
}
],
"compose" : {
"include" : [
{
"system" : "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
"concept" : [
{
"code" : "C101509",
"display" : "API/FDF ANALYTICAL TESTING"
},
{
"code" : "C101510",
"display" : "FDF MANUFACTURE"
},
{
"code" : "C101511",
"display" : "CLINICAL BIOEQUIVALENCE OR BIOAVALABILITY STUDY"
},
{
"code" : "C101512",
"display" : "IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING"
},
{
"code" : "C112113",
"display" : "Human Drug Compounding Outsourcing Facility"
},
{
"code" : "C117110",
"display" : "Business Entity Qualifier"
},
{
"code" : "C118411",
"display" : "Wholesale Drug Distributor"
},
{
"code" : "C118412",
"display" : "Third-Party Logistics Provider"
},
{
"code" : "C122061",
"display" : "Outsourcing Animal Drug Compounding"
},
{
"code" : "C125710",
"display" : "Transfill"
},
{
"code" : "C175317",
"display" : "SIP Foreign Seller"
},
{
"code" : "C201565",
"display" : "Distribute"
},
{
"code" : "C25391",
"display" : "ANALYSIS"
},
{
"code" : "C43360",
"display" : "MANUFACTURE"
},
{
"code" : "C70827",
"display" : "Salvage"
},
{
"code" : "C71586",
"display" : "EXPORT"
},
{
"code" : "C73330",
"display" : "UNITED STATES AGENT"
},
{
"code" : "C73599",
"display" : "IMPORT"
},
{
"code" : "C73606",
"display" : "REPACK"
},
{
"code" : "C73607",
"display" : "RELABEL"
},
{
"code" : "C73608",
"display" : "Distributes drug products under own private label"
},
{
"code" : "C82401",
"display" : "API MANUFACTURE"
},
{
"code" : "C82434",
"display" : "OUTSOURCING HUMAN DRUG COMPOUNDING"
},
{
"code" : "C84382",
"display" : "STERILIZE"
},
{
"code" : "C84386",
"display" : "PARTICLE SIZE REDUCTION"
},
{
"code" : "C84635",
"display" : "MEDICATED ANIMAL FEED MANUFACTURE"
},
{
"code" : "C84731",
"display" : "PACK"
},
{
"code" : "C84732",
"display" : "LABEL"
},
{
"code" : "C91403",
"display" : "POSITRON EMISSION TOMOGRAPHY DRUG PRODUCTION"
}
]
}
]
}
}